Xerox Stock Hits New 52-Week Low (XRX)

Editor's Note: TheStreet ratings do not represent the views of TheStreet's staff or its contributors. Ratings are established by computer based on metrics for performance (which includes growth, stock performance, efficiency and valuation) and risk (volatility and solvency). Companies with poor cash flow or high debt levels tend to earn lower ratings in our model.

NEW YORK ( TheStreet) -- Xerox Corporation (NYSE: XRX) hit a new 52-week low Wednesday as it is currently trading at $6.35, below its previous 52-week low of $6.36 with 3.6 million shares traded as of 12:55 p.m. ET. Average volume has been 10.4 million shares over the past 30 days.

Xerox has a market cap of $8.48 billion and is part of the consumer goods sector and consumer durables industry. Shares are down 18.5% year to date as of the close of trading on Tuesday.

Xerox Corporation provides business process and information technology (IT) outsourcing, and document management services worldwide. The company has a P/E ratio of 7.3, equal to the average consumer durables industry P/E ratio and below the S&P 500 P/E ratio of 17.7.

  • ACTIVE STOCK TRADERS: Get full access to Jim Cramer's thoughts for less than $3/week - sometimes before he says them on TV! Start with a 14-Day Free Trial.

TheStreet Ratings rates Xerox as a hold. The company's strengths can be seen in multiple areas, such as its attractive valuation levels, good cash flow from operations and expanding profit margins. However, as a counter to these strengths, we also find weaknesses including unimpressive growth in net income and a generally disappointing performance in the stock itself. You can view the full Xerox Ratings Report.

See all 52-week low stocks or get investment ideas from our investment research center.

FREE from Real Money's Jim Cramer: Winners and Losers Election 2012 - Steps to take NOW so you can profit no matter who is in charge! Free download now.
null

If you liked this article you might like

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Biotech Gold Rush Starts to Pick Up; Xerox, Fujifilm Saga Continues -- ICYMI

Xerox's Jacobson Defends Fuji Deal As Icahn Hovers

Xerox's Jacobson Defends Fuji Deal As Icahn Hovers

Big Xerox Investor Sues to Block Fuji Deal

Big Xerox Investor Sues to Block Fuji Deal

Carl Icahn Urges Xerox Shareholders to Block Fuji Deal

Carl Icahn Urges Xerox Shareholders to Block Fuji Deal

Cramer: Hunting for Bargains

Cramer: Hunting for Bargains